# Plain Language Summary: PI Post Acute Access Act

This bill makes it easier for people with primary immunodeficiency (a condition where the immune system doesn't work properly) to get treatment at skilled nursing facilities—places like nursing homes or rehabilitation centers where patients receive medical care after a hospital stay. Specifically, the bill ensures that Medicare will cover the supplies and equipment needed to give patients intravenous immune globulin (IVIG), which is a treatment that helps boost the immune system for people with this condition.

Right now, some patients with primary immunodeficiency struggle to access this treatment in nursing facilities because it's unclear whether Medicare will pay for all the necessary supplies and equipment involved. This bill removes that confusion by explicitly stating that Medicare must cover everything needed to administer IVIG at these facilities. For patients, this means they won't face unexpected bills or have to go to a hospital instead of a more convenient nursing facility for their treatment. For nursing facilities, it clarifies what they can bill Medicare for when treating these patients.

The change takes effect on January 1, 2024, so facilities and patients should start seeing the benefits at the beginning of that year. This is particularly important for people with primary immunodeficiency who need ongoing treatment but don't require full hospitalization—they can now receive care in a setting that's often more comfortable and less expensive than a hospital, with Medicare picking up the tab for the treatment supplies.

PI Post Acute Access Act

PI Post Acute Access Act This bill allows for separate payment under Medicare to skilled nursing facilities for items and services that are needed to administer intravenous immune globin (IVIG) to patients with primary immune deficiency diseases (rare genetic disorders that impair the immune system and increase vulnerability for other infections).